Female-founded Cytochroma secures £1m in grant funding and investment round
Summary
Cytochroma has also secured additional investment through multiple grants from Scottish Enterprise and Innovate UK as well as having had success in numerous business competitions which have provided significant funding to date. The company, which provides ethical, sustainable and accurate alternatives to animal testing in drug discovery and development plans to use the funding to expand its facilities, and grow its sales and technical team. It will also expand its service offering with plans to model a range of tissue and organs, including the development of mini-hearts to predict the safety and effect of new drugs and vaccines. Based at Roslin, near Edinburgh, a site with a long history of scientific innovation which was the home of Dolly the Sheep, Cytochroma is focused on providing its physiologically relevant models for ethical and accurate acceleration of drug discovery. Cytochroma has also built an ethically sourced, diverse induced pluripotent stem cell (iPSC) library which contains backgrounds of ethnic groups that are currently underrepresented in clinical trials.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
